Skip to main content
Equibles

MetLife Investment Management, LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,000,372
+$283,313 QoQ
Shares Held
55,700
+8.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 207 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. AMLX ranks #17 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in AMLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,000,372 55,700
2026-03-31 $717,059 51,587
2025-12-31 $599,820 49,654
2025-09-30 $583,405 42,929
2025-06-30 $275,174 42,929
2024-03-31 $39,101 13,768
2023-12-31 $393,200 26,712
2023-09-30 $489,096 26,712
2023-06-30 $576,177 26,712
2023-03-31 $783,730 26,712
2022-12-31 $987,008 26,712
2022-09-30 $547,827 19,461
2022-06-30 $130,679 6,785
2022-03-31 $87,187 6,785